{"domain":"labgeni.us","status":"valid","tier":"listed","authority":46,"verified":false,"title":"LabGenius Therapeutics","summary":"ML-driven Antibody Discovery","country":"US","country_source":"tld","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://labgeni.us/llms.txt","llms_full_txt":null,"last_checked":"2026-10-27T13:26:48.852Z","agent_terms":null,"categories":["science-research","ai-ml"],"capabilities":[],"inferred_tags":["antibody discovery","machine learning","therapeutics"],"audience":"mixed","agent_uses":[],"language":"en","platform_generated":false,"agent_summary":"LabGenius Therapeutics: machine-learning-driven antibody discovery company. The material is a one-line summary with no further detail.","llms_txt_cached":"https://agentwebmap.com/v1/domain/labgeni.us/llms.txt","agentic":"informational","section_keys":["company-values","events","investor-logos","pages","pipeline-items","posts","sitemaps","team-members"],"section_partial":false,"section_indexed_at":"2026-10-26T11:40:46.345Z"}